Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017

C Hiemke, N Bergemann, HW Clement… - …, 2018 - thieme-connect.com
Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …

Drugs commonly associated with weight change: a systematic review and meta-analysis

JP Domecq, G Prutsky, A Leppin… - The Journal of …, 2015 - academic.oup.com
Context: Various drugs affect body weight as a side effect. Objective: We conducted this
systematic review and meta-analysis to summarize the evidence about commonly …

[图书][B] The Maudsley prescribing guidelines in psychiatry

DM Taylor, TRE Barnes, AH Young - 2021 - books.google.com
The Maudsley Prescribing Guidelines in Psychiatry The new edition of the world-renowned
reference guide on the use of medications for patients presenting with mental health …

AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011

C Hiemke, P Baumann, N Bergemann… - …, 2011 - thieme-connect.com
Therapeutic drug monitoring (TDM), ie, the quantification of serum or plasma concentrations
of medications for dose optimization, has proven a valuable tool for the patient-matched …

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of …

A Hasan, P Falkai, T Wobrock… - The World Journal of …, 2012 - Taylor & Francis
These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in …

[PDF][PDF] Treatment of patients with schizophrenia

AF Lehman, LB Dixon, TH McGlashan… - American Psychiatric …, 2010 - umh1946.umh.es
Originally published in February 2004. This guideline is more than 5 years old and has not
yet been updated to ensure that it reflects current knowledge and practice. In accordance …

The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review

J Peuskens, L Pani, J Detraux, M De Hert - CNS drugs, 2014 - Springer
Since the 1970s, clinicians have increasingly become more familiar with hyperprolactinemia
(HPRL) as a common adverse effect of antipsychotic medication, which remains the …

Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs

NC Andreasen, M Pressler, P Nopoulos, D Miller… - Biological …, 2010 - Elsevier
BACKGROUND: A standardized quantitative method for comparing dosages of different
drugs is a useful tool for designing clinical trials and for examining the effects of long-term …

[HTML][HTML] Clinical pharmacology of atypical antipsychotics: an update

MC Mauri, S Paletta, M Maffini, A Colasanti… - EXCLI …, 2014 - ncbi.nlm.nih.gov
This review will concentrate on the clinical pharmacology, in particular pharmacodynamic
data, related to atypical antipsychotics, clozapine, risperidone, paliperidone, olanzapine …

Antipsychotic-induced weight gain: a comprehensive research synthesis

DB Allison, JL Mentore, M Heo… - American journal of …, 1999 - Am Psychiatric Assoc
OBJECTIVE: The purpose of this study was to estimate and compare the effects of
antipsychotics—both the newer ones and the conventional ones—on body weight …